GlassScriptPhysician profile
Timothy M Wiebe
NPI 1659428704
$484.43
in general payments reported to CMS, 2019-2025
8 companies · $23.54 in 2025
The $23.54 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.98 · 2020: $152 · 2021: $59.40 · 2022: $144 · 2023: $16.55 · 2024: $61.25 · 2025: $23.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $144.16 | 2022 | |
| Si-Bone, INC. | $104.41 | 2020 | |
| Integra Lifesciences Corporation | $91.93 | 2020-2021 | |
| Nalu Medical, INC. | $61.25 | 2024 | Nalu Neurostimulation System |
| Titan Spine, LLC | $27.98 | 2019 | |
| Medtronic, INC. | $23.54 | 2025 | Mazor X System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.55 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $14.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Wiebe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.